Holly L. Thacker

Source/Disclosures Published by: Disclosures: Jiang reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures. We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Holly L. Thacker, MD Menopausal hormone therapy (MHT) has complex cardio metabolic effects. Age, time since menopause, type and route of administration of MHT and concomitant disease are all factors in the response to MHT and the risk-benefit equation. In general, both estradiol and progesterone are vasodilatory but when given orally can lead to activation of the renin-angiotensin-aldosterone system.

Sometimes you’re in the mood to hit the sheets with your partner and other times it’s the last thing you want to do. But if you suffer from a condition called hypoactive sexual desire disorder (HSDD), you may experience not wanting to get frisky more often than not. Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services.